Publicaciones (60) Publicaciones de Antonio Jose Ruiz Alcaraz

2024

  1. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 109, Núm. 7, pp. 1781-1792

2023

  1. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Science of the Total Environment, Vol. 880

  2. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 6

  3. NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota

    Nutrients, Vol. 15, Núm. 13

  4. Optimizing the Preparation of Silk Fibroin Nanoparticles and Their Loading with Polyphenols: Towards a More Efficient Anti-Inflammatory Effect on Macrophages

    Pharmaceutics, Vol. 15, Núm. 1

  5. Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity

    Surgery for Obesity and Related Diseases, Vol. 19, Núm. 7, pp. 727-734

2022

  1. Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells

    Biomedicine and Pharmacotherapy, Vol. 149

  2. Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  3. Anti-inflammatory potential of digested Brassica sprout extracts in human macrophage-like HL-60 cells

    Food and Function, Vol. 14, Núm. 1, pp. 112-121

  4. Corrigendum to “Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells” [Biomed. Pharmacother. 149 (2022) 112804](S0753332222001925)(10.1016/j.biopha.2022.112804)

    Biomedicine and Pharmacotherapy

  5. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  6. Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review

    International Journal of Surgery, Vol. 104

  7. Gut Microbiome Modification through Dietary Intervention in Patients with Colorectal Cancer: Protocol for a Prospective, Interventional, Controlled, Randomized Clinical Trial in Patients with Scheduled Surgical Intervention for CRC

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  8. Leptin Signaling in Obesity and Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

  9. Membrane Vesicles for Nanoencapsulated SulforaphaneIncreased Their Anti-Inflammatory Role on an In Vitro Human Macrophage Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

  10. Potential of Sulforaphane and Broccoli Membrane Vesicles as Regulators of M1/M2 Human Macrophage Activity

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Recent insights into the characteristics and role of peritoneal macrophages from ascites of cirrhotic patients

    World Journal of Gastroenterology, Vol. 27, Núm. 41, pp. 7014-7024

  2. The role of peritoneal macrophages in endometriosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

2020

  1. Brassica bioactives could ameliorate the chronic inflammatory condition of endometriosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-20

  2. Child Head Circumference and Placental MFSD2a Expression Are Associated to the Level of MFSD2a in Maternal Blood During Pregnancy

    Frontiers in Endocrinology, Vol. 11